{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T13:50:10Z","timestamp":1725976210669},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,9,17]],"date-time":"2011-09-17T00:00:00Z","timestamp":1316217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00292-011-1478-3","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T16:13:06Z","timestamp":1316103186000},"page":"484-490","source":"Crossref","is-referenced-by-count":6,"title":["Pr\u00e4kanzer\u00f6se Ver\u00e4nderungen der Zervix","Precancerous lesions of the cervix"],"prefix":"10.1007","volume":"32","author":[{"given":"D.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,17]]},"reference":[{"key":"1478_CR1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.12.951-a","volume":"93","author":"Solomon","year":"2001","unstructured":"Solomon D, Schiffman M, Tarone R (2001) Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 93:293\u2013299","journal-title":"J Natl Cancer Inst"},{"key":"1478_CR2","doi-asserted-by":"crossref","first-page":"p","DOI":"10.1111\/j.1582-4934.2008.00631.x","volume":"13","author":"Arbyn","year":"2009","unstructured":"Arbyn M, Martin-Hirsch P, Buntinx F et al (2009) Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med 13:p 648\u2013659","journal-title":"J Cell Mol Med"},{"key":"1478_CR3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9378(03)00413-7","volume":"188","author":"ASCUS-LSIL","year":"2003","unstructured":"ASCUS-LSIL Triage Study (ALTS) group (2003) A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 188:1393\u20131400","journal-title":"Am J Obstet Gynecol"},{"key":"1478_CR4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/JCM.01674-10","volume":"49","author":"Clad","year":"2011","unstructured":"Clad A, Reuschenbach M, Weinschenk J et al (2011) Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology. J Clin Microbiol 49:1071\u20131076","journal-title":"J Clin Microbiol"},{"key":"1478_CR5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.1174","volume":"92","author":"Klaes","year":"2001","unstructured":"Klaes R, Friedrich T, Spitkovsky D et al (2001) Overexpression of p16(INK4\u00a0A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276\u2013284","journal-title":"Int J Cancer"},{"key":"1478_CR6","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e3181e8b2c4","volume":"34","author":"Galgano","year":"2010","unstructured":"Galgano MT, Castle PE, Atkins KA et al (2010) Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 34:1077\u20131087","journal-title":"Am J Surg Pathol"},{"key":"1478_CR7","doi-asserted-by":"crossref","first-page":"p22","DOI":"10.1186\/1746-1596-4-22","volume":"4","author":"Lesnikova","year":"2009","unstructured":"Lesnikova I, Lidang M, Hamilton-Dutoit S et al (2009) P16 as a diagnostic marker of cervical neoplasia: a tissue microarray study of 796 archival specimens. Diagn Pathol 4:p22","journal-title":"Diagn Pathol"},{"key":"1478_CR8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2559.2007.02652.x","volume":"50","author":"Regauer","year":"2007","unstructured":"Regauer S, Reich O (2007) CK17 and p16 expression patterns distinguish (atypical) immature squamous metaplasia from high-grade cervical intraepithelial neoplasia (CINIII). Histopathology 50:629\u2013635","journal-title":"Histopathology"},{"key":"1478_CR9","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/modpathol.2008.101","volume":"21","author":"Pinto","year":"2008","unstructured":"Pinto AP, Schlecht NF, Woo TY et al (2008) Biomarker (ProEx C, p16(INK4\u00a0A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics. Mod Pathol 21:1067\u20131074","journal-title":"Mod Pathol"},{"key":"1478_CR10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.pgp.0000139639.79105.40","volume":"23","author":"Branca","year":"2004","unstructured":"Branca M, Ciotti M, Santini D et al (2004) p16(INK4\u00a0A) expression is related to grade of CIN and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol 23:354\u2013365","journal-title":"Int J Gynecol Pathol"},{"key":"1478_CR11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/IGC.0b013e31821091ea","volume":"21","author":"Huang","year":"2011","unstructured":"Huang LW, Pan HS, Lin YH et al (2011) P16 methylation is an early event in cervical carcinogenesis. Int J Gynecol Cancer 21:452\u2013456","journal-title":"Int J Gynecol Cancer"},{"key":"1478_CR12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/PAS.0b013e31821534b9","volume":"35","author":"Park","year":"2011","unstructured":"Park KJ, Kiyokawa T, Soslow RA et al (2011) Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus. Am J Surg Pathol 35:633\u2013646","journal-title":"Am J Surg Pathol"},{"key":"1478_CR13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cncr.21378","volume":"105","author":"Wentzensen","year":"2005","unstructured":"Wentzensen N, Bergeron C, Cas F et al (2005) Evaluation of a nuclear score for p16INK4a-stained cervical squamous cells in liquid-based cytology samples. Cancer 105:461\u2013467","journal-title":"Cancer"},{"key":"1478_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cncr.22425","volume":"111","author":"Dehn","year":"2007","unstructured":"Dehn D, Torkko KC, Shroyer KR (2007) Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer 111:1\u201314","journal-title":"Cancer"},{"key":"1478_CR15","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1309\/0DGGQBDQAMJCJBXB","volume":"122","author":"Guo","year":"2004","unstructured":"Guo M, Hu L, Baliga M et al (2004) The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia. Am J Clin Pathol 122:894\u2013901","journal-title":"Am J Clin Pathol"},{"key":"1478_CR16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/cncy.20078","volume":"118","author":"Samarawardana","year":"2010","unstructured":"Samarawardana P, Dehn DL, Singh M et al (2010) p16(INK4a) is superior to high-risk human papillomavirus testing in cervical cytology for the prediction of underlying high-grade dysplasia. Cancer Cytopathol 118:146\u2013156","journal-title":"Cancer Cytopathol"},{"key":"1478_CR17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1309\/AJCP3CD9YKYFJDQL","volume":"134","author":"Denton","year":"2010","unstructured":"Denton KJ, Bergeron C, Klement P et al (2010) The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results. Am J Clin Pathol 134:12\u201321","journal-title":"Am J Clin Pathol"},{"key":"1478_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1309\/AJCP6OORTVEZRK7Y","volume":"134","author":"Stoler","year":"2010","unstructured":"Stoler MH (2010) Toward objective cervical cancer screening: maybe the eyes do have it. Am J Clin Pathol 134:5\u20136","journal-title":"Am J Clin Pathol"},{"key":"1478_CR19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","volume":"121","author":"Petry","year":"2011","unstructured":"Petry KU, Schmidt D, Scherbring S et al (2011) Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 dual-stained cytology. Gynecol Oncol 121:505\u2013509","journal-title":"Gynecol Oncol"},{"key":"1478_CR20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cncy.20140","volume":"119","author":"Schmidt","year":"2011","unstructured":"Schmidt D, Bergeron C, Denton KJ et al (2011) p16\/ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study. Cancer Cytopathol 119:158\u2013166","journal-title":"Cancer Cytopathol"},{"key":"1478_CR21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/gyno.2000.5847","volume":"78","author":"Bell","year":"2000","unstructured":"Bell MC, Crowley-Nowick P, Bradlow HL et al (2000) Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 78:123\u2013129","journal-title":"Gynecol Oncol"},{"key":"1478_CR22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1386-6532(09)70294-X","volume":"46","author":"Luyten","year":"2009","unstructured":"Luyten A, Scherbring S, Reinecke-Luthge A et al (2009) Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany \u2013 experience over 3 years. J Clin Virol 46(Suppl 3):5\u201310","journal-title":"J Clin Virol"},{"key":"1478_CR23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/cncr.22288","volume":"108","author":"Kelly","year":"2006","unstructured":"Kelly D, Kincaid E, Fansler Z et al (2006) Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C). Cancer 108:494\u2013500","journal-title":"Cancer"},{"key":"1478_CR24","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/cncr.22171","volume":"108","author":"Shroyer","year":"2006","unstructured":"Shroyer KR, Homer P, Heinz D et al (2006) Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology. Cancer 108:324\u2013330","journal-title":"Cancer"},{"key":"1478_CR25","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1158\/1055-9965.EPI-10-0818","volume":"20","author":"Depuydt","year":"2011","unstructured":"Depuydt CE, Makar AP, Ruymbeke MJ et al (2011) BD-ProExC as adjunct molecular marker for improved detection of CIN2\u2009+\u2009after HPV primary screening. Cancer Epidemiol Biomarkers Prev 20:628\u2013637","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1478_CR26","first-page":"241","volume":"26","author":"Griesser","year":"2004","unstructured":"Griesser H, Sander H, Hilfrich R et al (2004) Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild\/moderate dysplasia. Anal Quant Cytol Histol 26:241\u2013245","journal-title":"Anal Quant Cytol Histol"},{"key":"1478_CR27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.23366","volume":"114","author":"Yoshida","year":"2008","unstructured":"Yoshida T, Sano T, Kanuma T et al (2008) Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions. Cancer 114:83\u201388","journal-title":"Cancer"},{"key":"1478_CR28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/dc.21258","volume":"38","author":"Huang","year":"2010","unstructured":"Huang MZ, Li HB, Nie XM et al (2010) An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions. Diagn Cytopathol 38:573\u2013578","journal-title":"Diagn Cytopathol"},{"key":"1478_CR29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cncy.20061","volume":"118","author":"Yu","year":"2010","unstructured":"Yu L, Wang L, Zhong J et al (2010) Diagnostic value of p16INK4\u00a0A, Ki-67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens. Cancer Cytopathol 118:47\u201355","journal-title":"Cancer Cytopathol"},{"key":"1478_CR30","first-page":"78","volume":"30","author":"Hilfrich","year":"2008","unstructured":"Hilfrich R, Hariri J (2008) Prognostic relevance of human papillomavirus L1 capsid protein detection within mild and moderate dysplastic lesions of the cervix uteri in combination with p16 biomarker. Anal Quant Cytol Histol 30:78\u201382","journal-title":"Anal Quant Cytol Histol"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-011-1478-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-011-1478-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-011-1478-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T17:13:35Z","timestamp":1712855615000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-011-1478-3"}},"subtitle":["Biomarker in der zytologischen Diagnostik","Biomarkers in cytological diagnosis"],"short-title":[],"issued":{"date-parts":[[2011,9,17]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1478"],"URL":"https:\/\/doi.org\/10.1007\/s00292-011-1478-3","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,17]]}}}